Download
https://www.ndtvprofit.com/business/pharma-news-lupin-gets-five-us-fda-observations-for-its-visakhapatnam-plant?utm_source=telegram&utm_medium=referral&utm_campaign=socialshare
The U.S. FDA carried out inspection of Lupin’s Visakhapatnam plant between Jan. 13, 2020 and Jan. 17, 2020, the pharma firm says.
Share